World Health Organization Generic Protocol to Assess Drug-Resistant HIV Among Children <18 Months of Age and Newly Diagnosed With HIV in Resource-Limited Countries
Open Access
- 15 May 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 54 (suppl_4) , S254-S260
Abstract
Increased use of nonnucleoside reverse transcriptase inhibitors (NNRTIs) in pregnant and breastfeeding women will result in fewer children infected with human immunodeficiency virus (HIV). However, among children infected despite prevention of mother-to-child transmission (PMTCT), a substantial proportion will acquire NNRTI-resistant HIV, potentially compromising response to NNRTI-based antiretroviral therapy (ART). In countries scaling up PMTCT and pediatric ART programs, it is crucial to assess the proportion of young children with drug-resistant HIV to improve health outcomes and support national and global decision making on optimal selection of pediatric first-line ART. This article summarizes a new World Health Organization surveillance protocol to assess resistance using remnant dried blood spot specimens from a representative sample of children aged <18 months being tested for early infant diagnosis.Keywords
This publication has 33 references indexed in Scilit:
- Rapid Development of Antiretroviral Drug Resistance Mutations in HIV-Infected Children Less Than Two Years of Age Initiating Protease Inhibitor-Based Therapy in South AfricaAIDS Research and Human Retroviruses, 2011
- Surveillance of mother-to-child transmission prevention programmes at immunization clinics: the case for universal screeningAIDS, 2007
- Early Archiving and Predominance of Nonnucleoside Reverse Transcriptase Inhibitor–Resistant HIV‐1 among Recently Infected Infants Born in the United StatesThe Journal of Infectious Diseases, 2007
- Response to Antiretroviral Therapy after a Single, Peripartum Dose of NevirapineNew England Journal of Medicine, 2007
- Effects of Protease Inhibitors on Glucose Tolerance, Lipid Metabolism, and Body Composition in Children and Adolescents Infected With Human Immunodeficiency VirusEndocrine Practice, 2006
- Web Resources for HIV Type 1 Genotypic-Resistance Test InterpretationClinical Infectious Diseases, 2006
- Selection of Resistance Mutations in Children Receiving Prophylaxis With Lamivudine or Nevirapine for the Prevention of Postnatal Transmission of HIVJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
- Breast‐Milk Shedding of Drug‐Resistant HIV‐1 Subtype C in Women Exposed to Single‐Dose NevirapineThe Journal of Infectious Diseases, 2005
- Prevalence, incidence, and mother-to-child transmission of HIV-1 in rural South AfricaThe Lancet, 2002
- The effects of zidovudine in the subset of infants infected with human immunodeficiency virus type-1 (Pediatric AIDS Clinical Trials Group Protocol 076)The Journal of Pediatrics, 1999